Steve Harr - 06 Mar 2025 Form 4 Insider Report for Sana Biotechnology, Inc. (SANA)

Role: President & CEO, Director
Signature: /s/ Bernard J. Cassidy, Attorney-in-Fact for Steve Harr
Issuer symbol: SANA
Transactions as of: 06 Mar 2025
Net transactions value: -$32,819
Form type: 4
Filing time: 10 Mar 2025, 20:12:47 UTC
Previous filing: 08 Mar 2024
Next filing: 06 Mar 2026
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	SANA	Common Stock	Options Exercise	$0	+50,000	+0.64%	$0.000000	7,889,750	07 Mar 2025	Direct
transaction	SANA	Common Stock	Tax liability	$32,819	-12,820	-0.16%	$2.56	7,876,930	10 Mar 2025	Direct
holding	SANA	Common Stock						682,500	06 Mar 2025	Held by Harr Family Irrevocable Trust of 2015 dtd 12/28/2015
holding	SANA	Common Stock						167,000	06 Mar 2025	Held by Brian L Harr TTEE CCH Irrevocable Trust U/A DTD 03/25/2021	F1
holding	SANA	Common Stock						167,000	06 Mar 2025	Held by Brian L Harr TTEE JOH Irrevocable Trust U/A DTD 03/25/2021	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	SANA	Restricted Stock Units	Award	$0	+166,667		$0.000000	166,667	06 Mar 2025	Common Stock	166,667		Direct	F2, F3
transaction	SANA	Stock Option (Right to Buy)	Award	$0	+750,000		$0.000000	750,000	06 Mar 2025	Common Stock	750,000	$2.55	Direct	F4
transaction	SANA	Restricted Stock Units	Options Exercise	$0	-50,000	-25%	$0.000000	150,000	07 Mar 2025	Common Stock	50,000		Direct	F2, F5

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Brian L. Harr is the trustee of these trusts, whose sole beneficiaries are members of the reporting person's immediate family.
F2	Each restricted stock unit represents a contingent right to receive one share of Sana Biotechnology, Inc. ("Sana") common stock.
F3	The restricted stock units vest in four equal installments on each of March 6, 2026, 2027, 2028 and 2029, provided that the reporting person provides continuous service to Sana as an employee, consultant, director or officer of Sana through each such date.
F4	The option vests and becomes exercisable as to 25% of the underlying shares on March 6, 2026 and in 36 equal monthly installments thereafter, provided that the reporting person provides continuous service to Sana as an employee, consultant, director or officer of Sana through each such date.
F5	The award vested as to 25% of the restricted stock units on March 7, 2025 and the remaining restricted stock units will vest in three equal installments on each of March 7, 2026, 2027 and 2028, provided that the reporting person provides continuous service to Sana as an employee, consultant, director or officer of Sana through such date.